Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00949936
Other study ID # Ranier01/2008
Secondary ID
Status Completed
Phase N/A
First received July 30, 2009
Last updated October 14, 2010
Start date October 2009
Est. completion date June 2010

Study information

Verified date October 2010
Source Ranier Technology Limited
Contact n/a
Is FDA regulated No
Health authority United Kingdom: Medicines and Healthcare Products Regulatory AgencyBelgium: Federal Agency for Medicinal Products and Health ProductsNetherlands: The Central Committee on Research Involving Human Subjects (CCMO)
Study type Interventional

Clinical Trial Summary

The purpose of this European Union (EU) study to evaluate the safety and performance of the CAdiscTM-L Lumbar Spinal Disc Replacement Device in the surgical replacement of the lumbar intervertebral discs (L3 to S1) for patients requiring surgical intervention for total lumbar disc replacement for the treatment of debilitating, chronic low back pain.


Description:

Study Design: International, multicenter, open, clinical investigation with comparison to pre-operative

Currently there are two surgical procedures for the treatment of chronic low back pain: Spinal fusion and Total Disc Replacement. CAdisc™-L(Compliant Artificial disc - Lumbar) is a Lumbar total disc replacement product that preserves motion and restores disc height and stability

Surgical access is via a routine anterior approach with discectomy (removal of the diseased disc), which is performed prior to implantation of the CAdisc™-L. Instruments are then used to prepare the disc space and to controllably place the replacement disc at the target point. It is not intended for the surgery to differ in type, duration or risk to any other device of this nature.


Recruitment information / eligibility

Status Completed
Enrollment 0
Est. completion date June 2010
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 25 Years to 65 Years
Eligibility Inclusion Criteria:

- Male or non pregnant, non-lactating female

- Aged between 25-65 years (inclusive)

- BMI < 35

- Preoperative ODI > 30 points

- Chronic low back pain, and is in the opinion of the investigator a suitable candidate for anterior lumbar surgery

- Completed at least 6 months of conservative treatment without obtaining adequate symptomatic relief

- Degenerative disc changes at a single level between L3 - L4, or L4 - L5, or L5 - S1 as confirmed by positive discography and visualized by X-Ray, CT or MRI scan and/or with one or more of the following:

- Decrease in disc height < 50% (or up to 80% and no benefit from facet injections)

- Annular thickening

- Herniated nucleus pulpous

- Subject is able to give voluntary, written informed consent to participate in this investigation and from whom written consent must be obtained prior to enrolment.

Exclusion Criteria:

- Back or leg pain of unknown aetiology

- Radicular or sciatic pain which is more severe than low back pain

- Previous lumbar spinal surgery which could affect the trial outcome (e.g., disc replacement)

- Obvious signs of psychological or worker's compensation or litigation claim elements to their condition, or are actively engaged in such activities

- Subject is unwilling or unable to give consent or adhere to the follow-up programme

- Active infection or metastatic disease

- Non-degenerative spondylolisthesis

- Degenerative spondylolisthesis > grade 1

- Known allergy to any of the implant materials

- Osteoporosis (if suspected to be confirmed by bone density being 2.5SD below normal as assessed using DEXA analysis in post-menopausal females if suggested by X-ray or other risk factors)

- Osteopenia

- Bony lumbar stenosis

- Pars defect

- Isolated radicular compression syndromes, especially due to disc herniation

- Clinically compromised vertebral bodies at the affected levels due to current or past trauma

- Subject is skeletally immature as determined by the investigator

- Subject has participated in another clinical investigation or study with an investigational medical device within the last 60 days

- Concomitant medications that are known significantly to interfere with bone/soft tissue healing, e.g. steroids.

- Uncorrected iliac, aorto-iliac, or aortic aneurysm disease.

- Spinal instability (> 3mm translation or > 5° angulation) confirmed by functional radiological assessment.

- Degenerative disc changes at the L6 - S1 level

Study Design

Primary Purpose: Treatment


Intervention

Device:
CAdisc™-L (Total Disc Replacement)


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Ranier Technology Limited

Countries where clinical trial is conducted

Belgium,  Germany,  Netherlands,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Improvement of 15 points on the Oswestry Disability Index (ODI) scale at 3 months post-surgery, compared to baseline
See also
  Status Clinical Trial Phase
Completed NCT03243084 - Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy N/A
Suspended NCT04735185 - Stem Cells vs. Steroids for Discogenic Back Pain N/A
Completed NCT03162952 - RAND Center of Excellence for the Study of Appropriateness of Care in CAM
Completed NCT03240146 - Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain N/A
Completed NCT05282589 - Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients N/A
Completed NCT03637998 - Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain N/A
Recruiting NCT02289170 - Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100) N/A
Active, not recruiting NCT01944163 - The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain N/A
Completed NCT02231554 - Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial N/A
Recruiting NCT02063503 - Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients N/A
Terminated NCT01620775 - MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain N/A
Completed NCT01704677 - Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up N/A
Completed NCT01177241 - Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids N/A
Completed NCT01490905 - A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain Phase 4
Completed NCT01177254 - Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions N/A
Completed NCT01177280 - Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes N/A
Completed NCT00984815 - Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment Phase 3
Completed NCT00763321 - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP) Phase 3
Completed NCT00761150 - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP) Phase 3
Completed NCT00767806 - A Study for Patient With Chronic Low Back Pain Phase 3